Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Thyme Care provides value-based oncology management services designed to coordinate care for individuals diagnosed with cancer.
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Mindstrong is a virtual mental health platform.
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.
Khartis is a drug discovery company developing oral therapies for immune-mediated and chronic diseases, with a focus on treatments and care.
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.
ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Foresite Capital has invested in 130 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Foresite Capital's top investment sectors include Biotechnology, Health Care, Biopharma, Therapeutics, Medical. The firm invests across 19 different industry categories.
Among tracked funding rounds, Intellia Therapeutics received $400.0M in a Post-IPO Debt round. Foresite Capital's total known invested capital is $14.2B.
Foresite Capital's average investment size is $134.3M across its portfolio of 130 companies.
Recent Foresite Capital portfolio additions include Korsana Biosciences, Intellia Therapeutics, Thyme Care, Venatorx Pharmaceuticals, Mindstrong Health. These companies were founded in 2020 or later.